➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Litigation Details for Kowa Company, LTD. v. Orient Pharma Co., LTD. (N.D. Ill. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Kowa Company, LTD. v. Orient Pharma Co., LTD. (N.D. Ill. 2014)

Docket   Start Trial Date Filed 2014-05-07
Court District Court, N.D. Illinois Date Terminated 2014-11-26
Cause 35:271 Patent Infringement Assigned To Matthew F. Kennelly
Jury Demand None Referred To
Patents 6,465,477; 8,557,993
Attorneys David G. Conlin; David T Van Der Laan; Donald Joseph Mizerk; Gary Edward Hood; Katherine E Rohlf; Kathleen Bridget Carr; Mark Thomas Deming; William Allen Woolley
Firms Edwards Wildman Palmer LLP; Husch Blackwell LLP; Locke Lord LLP; Locke Lord LLP-West; Polsinelli PC
Link to Docket External link to docket
Small Molecule Drugs cited in Kowa Company, LTD. v. Orient Pharma Co., LTD.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Kowa Company, LTD. v. Orient Pharma Co., LTD. (N.D. Ill. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-05-07 1 14. United States Patent No. 6,465,477 (“the ‘477 patent”), entitled “Stable Pharmaceutical… The Patents in Suit 12. United States Patent No. 5,856,336 (“the ‘336 patent”), entitled…. This is an action for patent infringement arising under the patent laws of the United States, …assignment of the ‘336 patent, which expires on December 25, 2020 pursuant to a patent-term extension. KCL…licensee for the ‘336 patent and KPA holds a license from KCL for the ‘336 patent. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.